Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

If it hits $3.50, then my thoughts are all about a life of leisure... Unfortunately that Yahoo number is a meaningless leftover stat from years ago. There are no analysts currently on this stock.

You can't really put a price target on a no-revenue company like PVCT. If it can prove that it is achieving progress (since the board was replaced in March, progress has been good), and (even more importantly) it can get financing to last long enough to complete the trials (still a big question mark, but looking better with each piece of data we get), then we should get back to where it was before the delisting happened, which was around .50 (it traded at over $1 for much of its time on NYSE MKT, with higher spikes). There is also an element of time to rebuild trust holding this down, as well as its OTC status.

So far, we have gotten some good data and some good new patents with the new board in charge.

PV-10 trials are (were?) scheduled to be complete by February 2018. If progress has been made and the results are good, we are golden.

After the debacle that led to delisting, the news has only been good and it is flowing faster than it did before delisting. So, I think we will see a gradual rise; the chart has been trending upward since September.